In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to explore recent news updates and key advancements shaping the industry in 2025.

Register now – Feb. 18, 2026 - PACE/FL - Review the latest evidence, guidelines, strategies, and testing solutions for differentiating metabolic from alcohol-related liver injury.

Tuesday, March 10, 202611 a.m.–Noon CT Cost Free for all participants. Overview This webinar introduces real-time quaking-induced conversion (RT-QuIC) assays that are now available at[...]

A refreshed format of Mayo Clinic Laboratories’ “Answers From the Lab” podcast allows us to deliver even more valuable insights to listeners.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss recent news about drug-resistant infections. Later, Paul Jannetto, Ph.D., director of the Clinical and Forensic Toxicology Lab, Clinical Mass Spectrometry Lab, and Metals Lab, joins Dr. Pritt for the deep dive segment. Together, they explore how diagnostics are shaping the future of therapeutics.

Discover a checklist designed to help you create a positive experience that makes your lab patients’ preferred destination for laboratory services.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent regulatory and policy developments.

Presentation Recording Coming Soon - This webinar explores the rapidly evolving field of pharmacogenomics, with a special focus on the DPYD gene and its significance in oncology.

In the third quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.

This microlearning will familiarize users on MCL's AI-augmented kidney stone test along with the proper procedures for collecting and processing kidney stones to provide accurate, cost-effective, and timely analysis of the stones.

Artificial intelligence (AI) is reshaping laboratory medicine, not as a distant promise, but as a practical tool improving diagnostics, workflows, and quality. Through collaborative development, rigorous validation, and a commitment to ethical innovation, Mayo Clinic Laboratories is implementing AI-driven solutions that enhance precision, reduce turnaround times, and empower laboratorians to focus on what matters most: patient care.

Review ways of problem-solving through MDI and how it can best be applied in the workplace.

Ticks and mosquitoes are small but dangerous vectors that transmit a range of serious diseases, including Lyme disease, anaplasmosis, West Nile virus, and dengue. The severity of tick and mosquito seasons is influenced by environmental factors like climate, habitat, and host availability, and experts warn that rising temperatures may increase both the spread and complexity of these infections.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, discuss the latest developments in self-collection testing for women’s health and beyond.

Breaking away from an 80-year-old testing approach used to identify neurosyphilis infections, Mayo Clinic Laboratories has introduced a new, highly sensitive and specific method to confirm disease presence. The innovative test – the only one of its kind available in the U.S. – is IgG antibody index that detects antibodies specific to the disease-causing agent Treponema pallidum.